
It has been reported that Advent International Corp has pulled out of bidding for Pfizer’s stake in Brazilian generics manufacturer, …

The FDA has issued a warning letter to Pfizer after inspectors discovered that the plant did not protect properly against …

Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in the …

A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …

GBI Research examines whether the US continue to dominate the global generic drug market.

Eli Lilly has successfully won a major patent case against Teva Pharmaceuticals, with the case being decided at the US …
Mylan ended a difficult year for itself by releasing a rash of generics into the market, ending the year strongly …

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …

The industry is poised on the potential widespread adoption of many revolutionary technologies; foremost among them are biosimilars and generics, …

Teva Pharmacetuical, the Israel-based pharmaceutical company, submitted a document to the FDA on 30 October; the document outlines the differences …

Teva has announced that it has completed its acquisition of Actavis Generics, a subsidiary of Allergan, in a transaction valued …

A US district court judge has refused AstraZeneca’s request for a temporary restraining order blocking the approval of generic versions …

Teva Pharmaceuticals has announced that it has successfully finalised a bond sale totalling $15 billion that will help to fund …

Australia’s Mayne Pharma Group Ltd (ASX: MYX) said it will acquire US generic products from Israel-based drugmaker Teva Pharmaceuticals (NYSE: …

Impax Laboratories (NASDAQ: IPXL) has announced that it has entered into agreements with Teva and affiliates of Allergan to acquire …